Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
| Quarter | Letter Date | Fund Name | QTD | YTD | Tickers | Themes | Quick Take |
|---|---|---|---|---|---|---|---|
Buyside Digest is not affiliated with, and does not endorse, AVI Global Trust. This analysis is provided for institutional research purposes only and is not investment advice.
"AGT recorded a +0.4% NAV gain in December 2025, supported by positive restructuring developments at Chrysalis and continued accumulation of Samsung C&T at a steep -57% discount."
In December 2025, AVI Global Trust's (AGT) NAV increased by +0.4%. Chrysalis Investments was the largest positive contributor (+43bps) following the announcement of a proposed orderly wind-down of its assets, which AGT heavily supports as its largest shareholder. Vivendi was the largest detractor (-42bps). The manager highlights Samsung C&T as its largest Korean holding (now over 5% of NAV), pointing to its deep -57% discount and underlying crown-jewel stakes in Samsung Electronics and Samsung Biologics. Near-term catalysts include South Korean governance reforms and a capital allocation policy update expected in January 2026.
Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.
Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.
Market Conviction
High-conviction positioning: AGT recorded a +0.4% NAV gain in December 2025, supported by positive restructuring developments at Chrysalis and continued accumulation of Samsung C&T at a steep -57% discount....
Growth Outlook
Market outlook remains above average conviction: AGT recorded a +0.4% NAV gain in December 2025, supported by positive restructuring developments at Chrysalis and continued accumulation of Samsung C&T at a steep -57% discount....
Risk Appetite
Risk appetite posture is above average conviction: AGT recorded a +0.4% NAV gain in December 2025, supported by positive restructuring developments at Chrysalis and continued accumulation of Samsung C&T at a steep -57% discount....
Capital Deployment
Manager actively deployed capital into high-conviction opportunities. AGT recorded a +0.4% NAV gain in December 2025, supported by positive restructuring developments at Chrysalis and continued accumulation of Samsung C&T at a steep -57% discount....
Forward Guidance
Forward guidance signal: AGT recorded a +0.4% NAV gain in December 2025, supported by positive restructuring developments at Chrysalis and continued accumulation of Samsung C&T at a steep -57% discount....
Language Signal
Tone analysis indicates above average conviction language: AGT recorded a +0.4% NAV gain in December 2025, supported by positive restructuring developments at Chrysalis and continued accumulation of Samsung C&T at a steep -57% discount....
Perceived Risk
Perceived risk level is evaluated as moderate conviction. AGT recorded a +0.4% NAV gain in December 2025, supported by positive restructuring developments at Chrysalis and continued accumulation of Samsung C&T at a steep -57% discount....
Opportunity Density
Opportunity density index indicates high conviction actionable entry points. AGT recorded a +0.4% NAV gain in December 2025, supported by positive restructuring developments at Chrysalis and continued accumulation of Samsung C&T at a steep -57% discount....
Time Horizon
Investment time horizon reflects a above average conviction orientation. AGT recorded a +0.4% NAV gain in December 2025, supported by positive restructuring developments at Chrysalis and continued accumulation of Samsung C&T at a steep -57% discount....
